Pentobarbital will decrease the level or effect of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with CYP3A4 inducers could lead to a decrease Per mezzo di fentanyl plasma concentrations, lack of efficacy or, possibly, development of a withdrawal syndrome Con a patient who https://loanbookmark.com/story20384751/pentobarbital-vs-phenobarbital-una-panoramica